Target intelligence / Profile preview

Salmonella enterica serovar Typhi surface antigen (null (Vi antigen, O antigen, and H antigen are sometimes abbreviated, but no universal single abbreviation exists for all surface antigens))

Target
null (Vi antigen, O antigen, and H antigen are sometimes abbreviated, but no universal single abbreviation exists for all surface antigens)
Molecular classification
Capsular polysaccharide (Vi antigen), Lipopolysaccharide (O antigen), Flagellar protein (H antigen), Other: bacterial cell surface structures (collective term for surface antigens)
01

Overview

Surface antigens of Salmonella enterica serovar Typhi are a collection of cell envelope structures, notably including the Vi (capsular) antigen, O antigen (LPS side chain), and H antigen (flagellar protein). The Vi antigen is a capsular polysaccharide critical for virulence and target of several typhoid vaccines[1][7]. The O antigen, a polysaccharide component of lipopolysaccharide, is immunogenic and forms the basis of serological classification and certain vaccine approaches[3][5][9]. The H antigen is a flagellar protein that is phase-variable and important for motility, epidemiology, and serotyping[2][6][7]. These antigens are crucial determinants of host immune recognition, bacterial pathogenesis, serovar classification, and are exploited in medical diagnostics and therapeutic interventions, including vaccines[1][3][7][10]. If more specificity is needed for a particular antigen or drug interaction, further molecular details can be extracted from the serotyping system and vaccine literature[2][3][5][9][10].

Other names
Vi antigen (capsular polysaccharide)O antigen (LPS surface polysaccharide)H antigen (flagellar protein)Typhi surface antigensSalmonella Typhi antigens
02

Mechanism of action

Vaccine-induced immune response (e.g., Vi antigen stimulates antibody production that neutralizes or opsonizes the bacteria); Direct binding and agglutination (antisera and phages bind antigens to mediate bacterial killing or detection)

03

Biological functions

Immune evasion (Vi and O antigens protect against phagocytosis, complement, and immune recognition)Immune response induction (target of diagnostic tests and vaccines)Determination of serovar (basis for serological classification)Pathogenesis—virulence enhancement (capsule and LPS contribute to survival and infectivity)
04

Disease associations

Infection (central to causation and defense in typhoid fever)Other—inflammatory responses and sepsis (in some bacterial infections involving LPS and other antigens)
05

Safety considerations

Antigenic variation—potential impact on diagnostic sensitivity and vaccine coverageImmune evasion—Vi antigen may reduce effectiveness of host immune responsesVaccine efficacy—reliance on single antigens may not provide pan-serovar immunity
06

Interacting drugs

Typhoid vaccines (e.g., Vi polysaccharide vaccine; live attenuated Ty21a targets surface antigens)

2 more in the full profile.

07

Biomarkers

Anti-Vi antigen antibodiesAnti-O antigen antibodies (used in the Widal test)Anti-H antigen antibodies (also part of serodiagnosis)

Beyond the preview

Go deeper on Salmonella enterica serovar Typhi surface antigen (null (Vi antigen, O antigen, and H antigen are sometimes abbreviated, but no universal single abbreviation exists for all surface antigens)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Typhi surface antigen (null (Vi antigen, O antigen, and H antigen are sometimes abbreviated, but no universal single abbreviation exists for all surface antigens)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call